BioDelivery Sciences International, Inc.
BDSIUnited States
27 filed reports · 376 financial concepts
Latest figures
Group totals as stated in the company’s own filed reports, each with a link to its report. The change is against the same period a year earlier.
Latest fiscal year
Filed reports
27 reports · Jun 2015 to Dec 2021Each report counts once it has at least one extracted financial fact.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Quarterly · 10-QSEC EDGAR | 20 | 2,359 | Jun 2015 to Sep 2021 |
| Annual · 10-KSEC EDGAR | 7 | 2,915 | Dec 2015 to Dec 2021 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2021 | 10-K | 2021-12-31 | 2022-03-09 | 726 | Open |
| FY2021 Q3 | 10-Q | 2021-09-30 | 2021-11-03 | 195 | Open |
| FY2021 Q2 | 10-Q | 2021-06-30 | 2021-08-04 | 145 | Open |
| FY2021 Q1 | 10-Q | 2021-03-31 | 2021-05-06 | 146 | Open |
| FY2020 | 10-K | 2020-12-31 | 2021-03-11 | 438 | Open |
| FY2020 Q3 | 10-Q | 2020-09-30 | 2020-11-05 | 128 | Open |
| FY2020 Q2 | 10-Q | 2020-06-30 | 2020-08-05 | 102 | Open |
| FY2020 Q1 | 10-Q | 2020-03-31 | 2020-05-07 | 102 | Open |
| FY2019 | 10-K | 2019-12-31 | 2020-03-12 | 391 | Open |
| FY2019 Q3 | 10-Q | 2019-09-30 | 2019-11-12 | 140 | Open |
| FY2019 Q2 | 10-Q | 2019-06-30 | 2019-08-08 | 130 | Open |
| FY2019 Q1 | 10-Q | 2019-03-31 | 2019-05-06 | 118 | Open |
Financial data
376 concepts · 5,274 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial367 concepts · 5,071 facts · Dec 2013 to Dec 2021
- Cash and cash equivalents at carrying value41 · Dec 2013 to Dec 2021
- General and administrative expense (US GAAP)41 · Dec 2013 to Dec 2021
- Net income loss41 · Dec 2013 to Dec 2021
- Operating income loss41 · Dec 2013 to Dec 2021
- Other nonoperating income expense41 · Dec 2013 to Dec 2021
- Revenue41 · Dec 2013 to Dec 2021
- Operating expenses (US GAAP)40 · Dec 2013 to Dec 2021
- Accretion expense39 · Dec 2013 to Dec 2021
- Amortization of intangible assets39 · Dec 2013 to Dec 2021
- Depreciation39 · Dec 2013 to Dec 2021
- Increase decrease in accounts payable and accrued liabilities39 · Dec 2013 to Dec 2021
- Increase decrease in accounts receivable39 · Dec 2013 to Dec 2021
- Increase decrease in prepaid deferred expense and other assets39 · Dec 2013 to Dec 2021
- Share based compensation39 · Dec 2013 to Dec 2021
- Earnings per share basic38 · Mar 2014 to Dec 2021
- Earnings per share diluted38 · Mar 2014 to Dec 2021
- Increase decrease in inventories38 · Sep 2014 to Dec 2021
- Share based compensation arrangement by share based payment award options outstanding intrinsic value38 · Dec 2013 to Dec 2021
- Share based compensation arrangement by share based payment award options outstanding number38 · Dec 2013 to Dec 2021
- Share based compensation arrangement by share based payment award options outstanding weighted average exercise price38 · Dec 2013 to Dec 2021
- Stockholders equity (US GAAP)38 · Dec 2013 to Dec 2021
- Liabilities current37 · Dec 2014 to Dec 2021
- Other liabilities noncurrent37 · Dec 2014 to Dec 2021
- Payments to acquire property plant and equipment37 · Dec 2013 to Dec 2021
Product6 concepts · 190 facts · Dec 2013 to Dec 2021
- Revenue163 · Dec 2015 to Dec 2021
- Asset impairment charges10 · Dec 2013 to Dec 2021
- Cost of goods and services sold (US GAAP)6 · Dec 2016 to Dec 2021
- Income tax expense benefit6 · Mar 2017 to Dec 2017
- Business combination bargain purchase gain recognized amount3 · Mar 2017 to Dec 2017
- Cost of goods and services sold depreciation2 · Dec 2019 to Dec 2020
Geography3 concepts · 13 facts · Dec 2013 to Dec 2017
- Contracts revenue9 · Dec 2013 to Dec 2016
- Effective income tax rate reconciliation change in enacted tax rate2 · Dec 2017
- Potential Payments Upon Achievement Of Predetermined Sales2 · Dec 2015 to Mar 2016
Segments
203 factsFigures broken down by business line, region, product or another axis the company reports on.
Product or servicesrt:ProductOrServiceAxis9 members · 158 facts
- Bunavail [Member]31 · Dec 2016 to Dec 2021
- Belbuca [Member]25 · Mar 2017 to Dec 2021
- Product Sales [Member]25 · Dec 2016 to Dec 2021
- Product Royalty Revenues [Member]24 · Dec 2016 to Dec 2021
- Contract Revenues [Member]17 · Dec 2016 to Dec 2021
- Symproic17 · Dec 2017 to Dec 2021
- Research And Development Reimbursements [Member]7 · Dec 2016 to Dec 2019
- Shipping and Handling [Member]6 · Dec 2016 to Dec 2021
- Symproic [Member]6 · Mar 2018 to Sep 2019
Product or serviceus-gaap:ProductOrServiceAxis2 members · 32 facts
- Bunavail [Member]17 · Dec 2013 to Mar 2018
- Belbuca [Member]15 · Dec 2016 to Mar 2018
Statement geographicalus-gaap:StatementGeographicalAxis2 members · 12 facts
- U.S. [Member]11 · Dec 2013 to Dec 2016
- North Carolina [Member]1 · Dec 2017
Statement geographicalsrt:StatementGeographicalAxis1 member · 1 fact
- North Carolina [Member]1 · Dec 2017
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
No commentary or risk-factor text for this company.
Earnings calls
Transcripts with management claims and analyst questions, one per fiscal period.
No earnings-call transcripts for this company.
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Ask about this company in your AI model
Connect FactIQ to Claude, ChatGPT or another AI model (how to install), then paste this prompt.
Use FactIQ to get the revenue, net income and operating income of BioDelivery Sciences International, Inc. (BDSI) from its filed reports, for the last five fiscal years and the latest quarter or half year. Link each figure to its filing, and chart the trend.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Nov 19, 2026) and refreshed every few hours.